These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles. Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160 [TBL] [Abstract][Full Text] [Related]
4. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. Thomas R; Park IK; Jeong YY Int J Mol Sci; 2013 Jul; 14(8):15910-30. PubMed ID: 23912234 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging. Zhu J; Zhang B; Tian J; Wang J; Chong Y; Wang X; Deng Y; Tang M; Li Y; Ge C; Pan Y; Gu H Nanoscale; 2015 Feb; 7(8):3392-5. PubMed ID: 25584713 [TBL] [Abstract][Full Text] [Related]
6. Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. Ai F; Ferreira CA; Chen F; Cai W Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):619-30. PubMed ID: 26692551 [TBL] [Abstract][Full Text] [Related]
7. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis. Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592 [TBL] [Abstract][Full Text] [Related]
8. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging. Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381 [TBL] [Abstract][Full Text] [Related]
9. A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging. Gholami YH; Yuan H; Wilks MQ; Maschmeyer R; Normandin MD; Josephson L; El Fakhri G; Kuncic Z Int J Nanomedicine; 2020; 15():1253-1266. PubMed ID: 32161456 [TBL] [Abstract][Full Text] [Related]
10. Integrity of (111)In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Wang H; Kumar R; Nagesha D; Duclos RI; Sridhar S; Gatley SJ Nucl Med Biol; 2015 Jan; 42(1):65-70. PubMed ID: 25277378 [TBL] [Abstract][Full Text] [Related]
12. Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging. Chakravarty R; Valdovinos HF; Chen F; Lewis CM; Ellison PA; Luo H; Meyerand ME; Nickles RJ; Cai W Adv Mater; 2014 Aug; 26(30):5119-23. PubMed ID: 24944166 [TBL] [Abstract][Full Text] [Related]
13. Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI. Karageorgou MA; Bouziotis P; Stiliaris E; Stamopoulos D Nanomaterials (Basel); 2023 Jan; 13(3):. PubMed ID: 36770463 [TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. Misri R; Meier D; Yung AC; Kozlowski P; Häfeli UO Nanomedicine; 2012 Aug; 8(6):1007-16. PubMed ID: 22100757 [TBL] [Abstract][Full Text] [Related]
15. Radiolabeled ultra-small Fe Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578 [TBL] [Abstract][Full Text] [Related]
16. Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging. Sharma R; Xu Y; Kim SW; Schueller MJ; Alexoff D; Smith SD; Wang W; Schlyer D Nanoscale; 2013 Aug; 5(16):7476-83. PubMed ID: 23832243 [TBL] [Abstract][Full Text] [Related]
17. Dual nano-sized contrast agents in PET/MRI: a systematic review. Lahooti A; Sarkar S; Laurent S; Shanehsazzadeh S Contrast Media Mol Imaging; 2016 Nov; 11(6):428-447. PubMed ID: 28102031 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Madru R; Budassi M; Benveniste H; Lee H; Smith SD; Schlyer DJ; Vaska P; Knutsson L; Strand SE Cancer Biother Radiopharm; 2018 Aug; 33(6):213-220. PubMed ID: 30036073 [TBL] [Abstract][Full Text] [Related]
19. PET-MR and SPECT-MR multimodality probes: Development and challenges. Yang CT; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B Theranostics; 2018; 8(22):6210-6232. PubMed ID: 30613293 [TBL] [Abstract][Full Text] [Related]
20. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles. Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]